Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torstein Øverland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Clinical Immunology|December 21, 2018
Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion SyndromeDina M Aresvik, Torstein Øverland, Kari Lima, et al.
Journal of Clinical Immunology|March 11, 2020
Complement Activation in 22q11.2 Deletion SyndromeDina Grinde, Torstein Øverland, Kari Lima, et al.
Journal of Clinical Immunology|March 28, 2015
Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease FeaturesKiran A Gul, Torstein Øverland, Liv Osnes, et al.
Frontiers in Immunology|August 29, 2025
A Norwegian cohort with STAT1-related disease - further expanding the clinical phenotypeKaren Helene Bronken Martinsen, Torstein Øverland, Asbjørg Stray-Pedersen, et al.
Molecular Genetics & Genomic Medicine|November 30, 2016
A potential founder variant in <i>CARMIL2/RLTPR</i> in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunctionHanne S Sorte, Liv T Osnes, Børre Fevang, et al.
Frontiers in Immunology|August 6, 2020
Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined ImmunodeficiencyJanne Strand, Kiran Aftab Gul, Hans Christian Erichsen, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2016
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disordersAsbjørg Stray-Pedersen, Hanne Sørmo Sorte, Pubudu Samarakoon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Clinical Immunology|December 21, 2018
Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion SyndromeDina M Aresvik, Torstein Øverland, Kari Lima, et al.
Journal of Clinical Immunology|March 11, 2020
Complement Activation in 22q11.2 Deletion SyndromeDina Grinde, Torstein Øverland, Kari Lima, et al.
Journal of Clinical Immunology|March 28, 2015
Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease FeaturesKiran A Gul, Torstein Øverland, Liv Osnes, et al.
Frontiers in Immunology|August 29, 2025
A Norwegian cohort with STAT1-related disease - further expanding the clinical phenotypeKaren Helene Bronken Martinsen, Torstein Øverland, Asbjørg Stray-Pedersen, et al.
Molecular Genetics & Genomic Medicine|November 30, 2016
A potential founder variant in <i>CARMIL2/RLTPR</i> in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunctionHanne S Sorte, Liv T Osnes, Børre Fevang, et al.
Frontiers in Immunology|August 6, 2020
Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined ImmunodeficiencyJanne Strand, Kiran Aftab Gul, Hans Christian Erichsen, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2016
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disordersAsbjørg Stray-Pedersen, Hanne Sørmo Sorte, Pubudu Samarakoon, et al.
Pageof 1